Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)
Clinical trial NCT01287624 · COMPLETED
Trial details
- NCT number
- NCT01287624
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-03-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.